Article Details

Bluejay Therapeutics Received Regulatory Clearance to Initiate Clinical Studies of BJT-778 for

Retrieved on: 2022-12-01 19:48:53

Tags for this article:

Click the tags to see associated articles and topics

Bluejay Therapeutics Received Regulatory Clearance to Initiate Clinical Studies of BJT-778 for. View article details on hiswai:

Excerpt

... a best-in-class monoclonal antibody against hepatitis B surface ... IgG1 anti-HBs monoclonal antibodies and orally bioavailable liver-targeted ...

Article found on: www.elpasoinc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up